Production of Abnormal Prothrombin (PIVKA-II) by Hepatocellular Carcinoma. A Clinical and Experimental Study.

Acta Hepatologica Japonica - Japan
doi 10.2957/kanzo.27.1697
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Japan Society of Hepatology

Related search

Diagnostic Value of Prothrombin Induced by the Absence of Vitamin K or Antagonist-Ii (PIVKA-II) for Early Stage HBV Related Hepatocellular Carcinoma

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2017English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Fundamental and Clinical Evaluation of a PIVKA-II Kit, &Ldquo;PIVKA-Ii IRMA 'Daiichi, &Reg;”

RADIOISOTOPES
1999English

Clinicopathological Significance of Alpha-Fetoprotein and PIVKA-II Measurement in Operated Patients With Hepatocellular Carcinoma.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2000English

A Histopathological Study of Hepatocellular Carcinoma

Acta Hepatologica Japonica
Hepatology
1976English

A Phase II Study of Cixutumumab (IMC-A12, NSC742460) in Advanced Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2014English

Epidemiological and Clinical Characteristics of Egyptian Patients With Hepatocellular Carcinoma: A Single Center Study

International Journal of Medical and Health Sciences Research
2015English

Hepatocellular Carcinoma in Navarre: Study of Characteristics and Evolution in Clinical Practice

Anales del Sistema Sanitario de Navarra
Medicine
2016English

Somatostatin in Hepatocellular Carcinoma: Experimental and Therapeutic Implications

Hepatoma Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy